Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Charles E. Protzman"'
Autor:
Craig Struble, Yariv Donde, Yanbin Liang, R. M. Burk, Charles E. Protzman, Achim H.-P. Krauss, D.F. Woodward, Jenny W. Wang, K Landsverk, A.L. Nieves
Publikováno v:
British Journal of Pharmacology. 150:342-352
Background and Purpose: The prostamides (prostaglandin-ethanolamides) and prostaglandin (PG) glyceryl esters are biosynthesized by COX-2 from the respective endocannabinoids anandamide and 2-arachidonyl glycerol. Agonist studies suggest that their ph
Autor:
Victor M. Guzman, Yanbin Liang, Albert J. Evinger, Charles E. Protzman, Chen Li, David F. Woodward, Achim H.-P. Krauss
Publikováno v:
Journal of Biological Chemistry. 278:27267-27277
Connective tissue growth factor (CTGF) and Cyr61 (cysteine-rich angiogenic protein 61) are members of the CCN gene family that encode multifunctional, extracellular matrix-associated signaling proteins. Because the mechanism of action of certain anti
Autor:
Charles E. Protzman, Alex Kharlamb, Chen Li, Achim H.-P. Krauss, Karen M. Kedzie, Steven W. Andrews, Heather A. Krauss, Randy Chen, Madhu Cherukury, Diane D.-S. Tang-Liu, Devin F. Welty, Yanbin Liang, David F. Woodward, Michael E. Garst, Darius M. Babusis, June Chen, Robert M. Burk, Larry A. Wheeler, A.M. Bogardus, Daniel W. Gil
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 305:772-785
Replacement of the carboxylic acid group of prostaglandin (PG) F(2alpha) with a nonacidic moiety, such as hydroxyl, methoxy, or amido, results in compounds with unique pharmacology. Bimatoprost (AGN 192024) is also a pharmacologically novel PGF(2alph
Autor:
John W. Regan, Charles E. Protzman, Hiromichi Fujino, Achim H.-P. Krauss, Dinesh Srinivasan, Kristen L. Pierce, David F. Woodward
Publikováno v:
Journal of Biological Chemistry. 275:29907-29914
Prostaglandin F(2 alpha) (PGF(2 alpha)) receptors are G-protein-coupled receptors consisting of two alternative mRNA splice variants, named FP(A) and FP(B). As compared with the FP(A) isoform, the FP(B) isoform lacks the last 46 amino acids of the ca
Autor:
Achim H.-P. Krauss, Charles E. Protzman, Licheng Shi, R. M. Burk, R. Chen, Steven W. Andrews, George Sachs, H. T. T. Dinh, Heather A. Krauss, Karen M. Kedzie, A.M. Bogardus, L. J. Kaplan, Michael B. Roof, M. E. Garst, Ming Fai Chan, Larry A. Wheeler, R. A. Ross, John W. Regan, Todd S. Gac, June Chen, Kristen L. Pierce, D.F. Woodward, D. W. Gil
Publikováno v:
British Journal of Pharmacology. 130:1933-1943
Replacement of the carboxylic acid group of PGF(2alpha) with the non-acidic substituents hydroxyl (-OH) or methoxy (-OCH(3)) resulted in an unexpected activity profile. Although PGF(2alpha) 1-OH and PGF(2alpha) 1-OCH(3) exhibited potent contractile e
Autor:
Achim H.-P. Krauss, Todd S. Gac, Robert M. Burk, Linda L. Gibson, Charles E. Protzman, David F. Woodward, Michael E. Garst
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 4:2103-2106
A series of 3-oxo-2,4-dioxobicyclo[3.2.1]octanes (1–4) was synthesized and identified as potent thromboxane (TXA2) receptor agonists. Replacement of the terminal -COOH group resulted in an unexpected change in biological activity: platelet aggregat
Autor:
D.F. Woodward, Achim H.-P. Krauss, R. M. Burk, Linda L. Gibson, Todd S. Gac, M. E. Garst, Charles E. Protzman
Publikováno v:
ChemInform. 26
Autor:
David F. Woodward, Larry A. Wheeler, C.S. Spada, Achim H.-P. Krauss, Charles E. Protzman, June Chen, A.L. Nieves, David F. Scott, George Sachs
Publikováno v:
Experimental eye research. 80(1)
Bimatoprost is a synthetic analog of prostaglandin F(2 alpha) ethanolamide (prostamide F(2 alpha)), and shares a pharmacological profile consistent with that of the prostamides. Like prostaglandin F(2 alpha) carboxylic acid, bimatoprost potently lowe
Autor:
Filomena Fezza, T. Bisogno, Isabel Matias, V. Di Marzo, Alessia Ligresti, R. M. Burk, Yanbin Liang, Chen Li, Karen M. Kedzie, June Chen, Achim H.-P. Krauss, A.L. Nieves, Licheng Shi, David F. Woodward, L. De Petrocellis, Charles E. Protzman
Publikováno v:
The Journal of pharmacology and experimental therapeutics
309 (2004): 745–757. doi:10.1124/jpet.103.061705
info:cnr-pdr/source/autori:Matias I, Chen J, De Petrocellis L, Bisogno T, Ligresti A, Fezza F, Krauss AH, Shi L, Protzman CE, Li C, Liang Y, Nieves AL, Kedzie KM, Burk RM, Di Marzo V, Woodward DF./titolo:Prostaglandin ethanolamides (prostamides): in vitro pharmacology and metabolism./doi:10.1124%2Fjpet.103.061705/rivista:The Journal of pharmacology and experimental therapeutics (Print)/anno:2004/pagina_da:745/pagina_a:757/intervallo_pagine:745–757/volume:309
(2004).
info:cnr-pdr/source/autori:Matias I, Chen J, De Petrocellis L, Bisogno T, Ligresti A, Fezza F, Krauss AH, Shi L, Protzman CE, Li C, Liang Y, Nieves AL, Kedzie KM, Burk RM, Di Marzo V, Woodward DF./titolo:Prostaglandin ethanolamides (prostamides): in vitro pharmacology and metabolism./doi:/rivista:The Journal of pharmacology and experimental therapeutics (Print)/anno:2004/pagina_da:/pagina_a:/intervallo_pagine:/volume
309 (2004): 745–757. doi:10.1124/jpet.103.061705
info:cnr-pdr/source/autori:Matias I, Chen J, De Petrocellis L, Bisogno T, Ligresti A, Fezza F, Krauss AH, Shi L, Protzman CE, Li C, Liang Y, Nieves AL, Kedzie KM, Burk RM, Di Marzo V, Woodward DF./titolo:Prostaglandin ethanolamides (prostamides): in vitro pharmacology and metabolism./doi:10.1124%2Fjpet.103.061705/rivista:The Journal of pharmacology and experimental therapeutics (Print)/anno:2004/pagina_da:745/pagina_a:757/intervallo_pagine:745–757/volume:309
(2004).
info:cnr-pdr/source/autori:Matias I, Chen J, De Petrocellis L, Bisogno T, Ligresti A, Fezza F, Krauss AH, Shi L, Protzman CE, Li C, Liang Y, Nieves AL, Kedzie KM, Burk RM, Di Marzo V, Woodward DF./titolo:Prostaglandin ethanolamides (prostamides): in vitro pharmacology and metabolism./doi:/rivista:The Journal of pharmacology and experimental therapeutics (Print)/anno:2004/pagina_da:/pagina_a:/intervallo_pagine:/volume
We investigated whether prostaglandin ethanolamides (prostamides) E(2), F(2alpha), and D(2) exert some of their effects by 1) activating prostanoid receptors either per se or after conversion into the corresponding prostaglandins; 2) interacting with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b535cc10c39bd5637d09333513bc6d7
http://www.cnr.it/prodotto/i/167314
http://www.cnr.it/prodotto/i/167314
Autor:
Todd S. Gac, Robert M. Burk, David F. Woodward, Judith Senior, Achim H.-P. Krauss, Charles E. Protzman, Farhat Abbass, Linda L. Gibson, Kay Marshall
Publikováno v:
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics. 13(4)
The pharmacological activity of two novel thromboxane A2 (TxA2)-mimetics, AGN191976 and AGN192093, was investigated in vitro, using standard organ bath assays and human platelets, to determine potency and selectivity at various prostanoid (PG-) recep